NCT07553481

Chemotherapy-Induced Hearing Loss and Health Inequality

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-05-02Est. Completion: 2028-09-01

Enrollment target: 172 participants

Locations

Contact

Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer

The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and als…

Detroit, United StatesCompleted Sep 30, 2026

Lung NeoplasmsNeoadjuvant TherapyImmunotherapyMinimal Residual Disease

This study is a prospective single-arm clinical trial targeting patients with stage IB-IIIA non-small cell lung cancer (…

Beijing, ChinaEst. completion Oct 31, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.